[go: up one dir, main page]

GR3026467T3 - Imidazole compounds, their preparation and use - Google Patents

Imidazole compounds, their preparation and use

Info

Publication number
GR3026467T3
GR3026467T3 GR980400651T GR980400651T GR3026467T3 GR 3026467 T3 GR3026467 T3 GR 3026467T3 GR 980400651 T GR980400651 T GR 980400651T GR 980400651 T GR980400651 T GR 980400651T GR 3026467 T3 GR3026467 T3 GR 3026467T3
Authority
GR
Greece
Prior art keywords
preparation
imidazole compounds
compounds
epilepsia
parkinsonism
Prior art date
Application number
GR980400651T
Other languages
English (en)
Inventor
Oskar Axelsson
Mikkel Thaning
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of GR3026467T3 publication Critical patent/GR3026467T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
GR980400651T 1991-06-24 1998-03-27 Imidazole compounds, their preparation and use GR3026467T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72002191A 1991-06-24 1991-06-24

Publications (1)

Publication Number Publication Date
GR3026467T3 true GR3026467T3 (en) 1998-06-30

Family

ID=24892332

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400651T GR3026467T3 (en) 1991-06-24 1998-03-27 Imidazole compounds, their preparation and use

Country Status (14)

Country Link
EP (1) EP0520200B1 (el)
JP (1) JPH05186432A (el)
AT (1) ATE163290T1 (el)
AU (1) AU653816B2 (el)
CA (1) CA2071793A1 (el)
DE (1) DE69224448T2 (el)
DK (1) DK0520200T3 (el)
ES (1) ES2113898T3 (el)
FI (1) FI922905L (el)
GR (1) GR3026467T3 (el)
IE (1) IE921650A1 (el)
NO (1) NO302119B1 (el)
NZ (1) NZ242951A (el)
ZA (1) ZA924117B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
US5554630A (en) * 1993-03-24 1996-09-10 Neurosearch A/S Benzimidazole compounds
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
TR199701219T1 (xx) * 1995-04-21 1998-03-21 Neurosearch A/S Benzimidazol bile�ikleri, bu bile�ikleri i�eren ispen�iyar� bile�ikler.
EP0997147B1 (en) * 1997-07-08 2006-03-15 Ono Pharmaceutical Co., Ltd. Amino acid derivatives
CA2315910A1 (en) * 1997-12-22 1999-07-01 Ajinomoto Co., Inc. Novel dihydropyridine derivative
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
WO2000001676A1 (en) * 1998-07-02 2000-01-13 Neurosearch A/S Potassium channel blocking agents
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
KR100633349B1 (ko) 1998-07-14 2006-10-16 오노 야꾸힝 고교 가부시키가이샤 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
US6316440B1 (en) 1998-07-30 2001-11-13 Warner-Lambert Company Reduced dipeptide analogues as calcium channel antagonists
WO2000078719A1 (fr) 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Derive de la dihydropyridine
SK287527B6 (sk) * 2000-01-14 2011-01-04 Bayer Schering Pharma Aktiengesellschaft 1,2-Diarylbenzimidazoly a ich farmaceutické použitie
US7115645B2 (en) 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
US7329679B2 (en) 2000-01-27 2008-02-12 Schering Aktiengesellschaft 1,2 Diarylbenzimidazoles and their pharmaceutical use
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
KR100873400B1 (ko) * 2002-10-17 2008-12-11 한국과학기술연구원 Ｎ-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments

Also Published As

Publication number Publication date
EP0520200A2 (en) 1992-12-30
ZA924117B (en) 1993-03-31
NZ242951A (en) 1994-12-22
NO922475L (no) 1992-12-28
FI922905A0 (fi) 1992-06-22
FI922905L (fi) 1992-12-25
AU653816B2 (en) 1994-10-13
AU1726792A (en) 1993-01-07
CA2071793A1 (en) 1992-12-25
DE69224448T2 (de) 1998-06-10
ES2113898T3 (es) 1998-05-16
EP0520200B1 (en) 1998-02-18
DK0520200T3 (da) 1998-09-23
EP0520200A3 (en) 1993-05-12
DE69224448D1 (de) 1998-03-26
JPH05186432A (ja) 1993-07-27
IE921650A1 (en) 1992-12-30
ATE163290T1 (de) 1998-03-15
NO302119B1 (no) 1998-01-26
NO922475D0 (no) 1992-06-23

Similar Documents

Publication Publication Date Title
GR3026467T3 (en) Imidazole compounds, their preparation and use
MY131298A (en) 5-heteroyl indole derivatives
SI0725779T1 (el)
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
AU2626492A (en) 2- aminomethyl-chromans
BG101118A (en) Therapeutical compounds
HK1029916A1 (en) Use of inosine for the manufacture of a medicamentfor stimulating axonal outgrowth of central nervous system neurons.
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
ITRM910085A0 (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina
ZA932062B (en) Indole and indazole derivatives, for the treatment and prophylaxis of cerabral disorders, their preparation and their use
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.